Fullbrook Thorpe Investments logo

Fullbrook Thorpe Investments

Europe, Derbyshire, United Kingdom, Willington

Description

Fullbrook Thorpe Investments is a private equity fund that invests both directly and as partners with other private equity businesses.

Investor Profile

Fullbrook Thorpe Investments has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (25%)
  • Series A (25%)
  • Seed (25%)
  • Post Ipo Equity (25%)

Country Focus

  • United Kingdom (75%)
  • Canada (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Car Sharing
  • Rental
  • Agriculture
  • Agtech
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fullbrook Thorpe Investments frequently co-invest with?

Adjuvo
Europe, England, United Kingdom, London
Co-Investments: 1
LDC
Europe, England, United Kingdom, London
Co-Investments: 2
Salix Pharmaceuticals
North America, North Carolina, United States, Raleigh
Co-Investments: 2

Which angels does Fullbrook Thorpe Investments often collaborate with?

NW
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Fullbrook Thorpe Investments?

HEMPALTA

Calgary, Alberta, Canada

HEMPALTA is an agricultural technology company focused on innovative hemp processing and product creation.

AgricultureAgTechManufacturing
Post Ipo EquityMar 19, 2024
Karshare

London, England, United Kingdom

Karshare is a community car-sharing platform.

Car SharingRental
SeedAug 9, 2021
Amount Raised: $4,153,951
Atlantic Healthcare

Saffron Walden, Essex, United Kingdom

A rare disease pharmaceutical company acquiring, developing and commercializing therapeutics, specializing in gastroenterology.

BiotechnologyHealth CarePharmaceutical
Series BNov 1, 2016
Amount Raised: $24,000,000
Atlantic Healthcare

Saffron Walden, Essex, United Kingdom

A rare disease pharmaceutical company acquiring, developing and commercializing therapeutics, specializing in gastroenterology.

BiotechnologyHealth CarePharmaceutical
Series AJan 1, 2013
Amount Raised: $23,100,000